GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (OSTO:BIOTECO) » Definitions » Valuation Rank

ArcticZymes Technologies ASA (OSTO:BIOTECO) Valuation Rank


View and export this data going back to 2012. Start your Free Trial

What is ArcticZymes Technologies ASA Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

ArcticZymes Technologies ASA Valuation Rank Related Terms

Thank you for viewing the detailed overview of ArcticZymes Technologies ASA's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

ArcticZymes Technologies ASA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (OSTO:BIOTECO) » Definitions » Valuation Rank
Comparable Companies
OSL:NYKD OSL:TRMED OSL:HBC OSL:BGBIO OSL:LYTIX OSL:EXTX OSL:ABTEC OSL:ONCIN OSL:ABS OSL:ULTI VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
AZT:Norway 0DRV:UK B4V:Germany
Address
Sykehusveien 23, Tromso, NOR, 9294
Website
https://www.arcticzymes.com
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Germany, Italy, France, and other countries.